- Home
- POR vs ALKS Comparison
POR vs ALKS Comparison
Compare POR & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POR
- ALKS
- Stock Information
- Founded
- POR 1889
- ALKS 1987
- Country
- POR United States
- ALKS Ireland
- Employees
- POR N/A
- ALKS N/A
- Industry
- POR Electric Utilities: Central
- ALKS Biotechnology: Pharmaceutical Preparations
- Sector
- POR Utilities
- ALKS Health Care
- Exchange
- POR Nasdaq
- ALKS Nasdaq
- Market Cap
- POR 4.9B
- ALKS 4.5B
- IPO Year
- POR N/A
- ALKS 1991
- Fundamental
- Price
- POR $42.44
- ALKS $30.13
- Analyst Decision
- POR Hold
- ALKS Buy
- Analyst Count
- POR 11
- ALKS 12
- Target Price
- POR $45.78
- ALKS $38.33
- AVG Volume (30 Days)
- POR 965.0K
- ALKS 1.9M
- Earning Date
- POR 04-25-2025
- ALKS 05-01-2025
- Dividend Yield
- POR 4.95%
- ALKS N/A
- EPS Growth
- POR 8.87
- ALKS N/A
- EPS
- POR 2.86
- ALKS 2.09
- Revenue
- POR $3,439,000,000.00
- ALKS $1,513,770,000.00
- Revenue This Year
- POR $4.88
- ALKS N/A
- Revenue Next Year
- POR $4.35
- ALKS $4.09
- P/E Ratio
- POR $14.83
- ALKS $14.50
- Revenue Growth
- POR 10.79
- ALKS N/A
- 52 Week Low
- POR $40.05
- ALKS $22.90
- 52 Week High
- POR $49.85
- ALKS $36.45
- Technical
- Relative Strength Index (RSI)
- POR 48.65
- ALKS 51.87
- Support Level
- POR $41.40
- ALKS $29.78
- Resistance Level
- POR $42.94
- ALKS $31.99
- Average True Range (ATR)
- POR 0.84
- ALKS 1.04
- MACD
- POR 0.07
- ALKS 0.42
- Stochastic Oscillator
- POR 54.31
- ALKS 64.09
About POR Portland General Electric Co
Portland General Electric is a regulated electric utility providing generation, transmission, and distribution services in a service territory that includes about half of all Oregon residents and two thirds of the state's business activity. The company owns (wholly or through joint ventures) 3.5 gigawatts of gas, coal, wind, and hydro generation.
About ALKS Alkermes plc
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.